Cargando…
Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability
BACKGROUND: Breast cancers that harbor mismatch-repair (MMR) deficiency and/or microsatellite instability (MSI) might be sensitive to immune checkpoint blockade, but there are currently no specific guidelines for assessing MMR status in breast cancer. Here, we sought to define the clinical value of...
Autores principales: | Fusco, Nicola, Lopez, Gianluca, Corti, Chiara, Pesenti, Chiara, Colapietro, Patrizia, Ercoli, Giulia, Gaudioso, Gabriella, Faversani, Alice, Gambini, Donatella, Michelotti, Anna, Despini, Luca, Blundo, Concetta, Vaira, Valentina, Miozzo, Monica, Ferrero, Stefano, Bosari, Silvano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649738/ https://www.ncbi.nlm.nih.gov/pubmed/31360876 http://dx.doi.org/10.1093/jncics/pky056 |
Ejemplares similares
-
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
por: Lopez, Gianluca, et al.
Publicado: (2020) -
Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab
por: Invernizzi, Marco, et al.
Publicado: (2019) -
Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up
por: Invernizzi, Marco, et al.
Publicado: (2018) -
A New Mouse Avatar Model of Non-Small Cell Lung Cancer
por: Russo, Maria Veronica, et al.
Publicado: (2015) -
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
por: Sajjadi, Elham, et al.
Publicado: (2021)